Goldman Sachs: Innovator ETF Acquisition Looks Rich, but Strategic Alignment Makes Sense
The move bolsters Goldman’s asset and wealth management business.

Key Morningstar Metrics for Goldman Sachs
- Fair Value Estimate: $630.00
- Morningstar Rating: ★★
- Morningstar Economic Moat Rating: Wide
- Morningstar Uncertainty Rating: High
Goldman Sachs GS announced a $2 billion acquisition of Innovator ETF, as reported by Bloomberg. Innovator boasts $28 billion in assets under management and has an estimated 35%-40% market share in the quickly growing structured outcome ETF market.
Why it matters: The move bolsters Goldman’s asset and wealth management business, which has been a recent focal point for leadership. This is the firm’s third transaction in the segment since September 2025.
- Goldman has prioritized the development of its steadier fee-income businesses since the great financial crisis, with AWM now representing around 30% of post-provision net revenue.
- We see some benefit from Goldman’s willingness to invest ahead of the curve in less-commoditized areas like venture capital, diverse alternative asset exposure, and structured outcome products. The firm’s ultra-high-net-worth clients may still struggle to access an array of alternative assets—at least, on one competing platform.
- Structured outcome ETFs are particularly attractive for their high fee rates (roughly 0.80%) and popularity with financial advisors.
The bottom line: Given the small scale of the transaction (less than 2% of Goldman’s intraday market cap), we don’t expect to change our $630 per share fair value estimate. The company’s shares are trading at a nearly 30% premium to our estimate of intrinsic valuation.
- While the deal looks expensive at 7.1% of acquired AUM (against a 5.4% average for comparable alternative asset manager transactions with similar fee rates during October 2023-April 2025), the ability to cross-sell Innovator’s products through Goldman’s robust distribution platform could ultimately justify the premium paid.
- We plan to maintain our Standard Capital Allocation Rating for the firm, with the deal looking unlikely to materially create or destroy value for shareholders over the medium term.
Editor’s Note: This analysis was originally published as a stock note by Morningstar Equity Research.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
